Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc.HEPA · Entity 8208 | Director | February 19, 2024 | February 22, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hepion Pharmaceuticals, Inc.
Report date February 19, 2024 · Filed February 22, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.56 · Expires 2034-02-19 | Direct | 99,562 |
Reported balance
After 2024-02-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-02-19 · Grant · Acquired 85,000 · Balance 99,562 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2024 Filed Feb 22, 2024 01:01 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | GrantStock Options · Derivative | 85,000 | $0.00 Strike: $2.56 | $0.00 |
DisclosureSEC source: 0001493152-24-007465 · ownership.xml · derivative · entry 1 Block Timothy M. · CIK 0001593465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,562 Underlying: Common Stock · 85,000 shares Expires 2034-02-19 Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:34 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | GrantStock Options · Derivative | 200,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001104659-21-069935 · tm2117144-2_4seq1.xml · derivative · entry 1 Block Timothy M. · CIK 0001593465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,276 Underlying: Common Stock · 200,000 shares Expires 2031-05-18 F1 · security: Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:17 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | GrantStock Options · Derivative | 30,000 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001104659-20-097599 · a4.xml · derivative · entry 1 Block Timothy M. · CIK 0001593465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,276 Underlying: Common Stock · 30,000 shares Expires 2030-08-19 Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 20:14 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | GrantStock Options · Derivative | 60,000 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0001104659-20-044174 · a4.xml · derivative · entry 1 Block Timothy M. · CIK 0001593465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,220 Underlying: Common Stock · 60,000 shares Expires 2030-04-03 Read SEC document |
| July 24, 2019 Filed Jul 25, 2019 20:15 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | GrantStock Options · Derivative | 970 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001104659-19-041847 · a4.xml · derivative · entry 1 Block Timothy M. · CIK 0001593465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,220 Underlying: Common Stock · 970 shares Expires 2029-07-24 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.